Skip to content
OpenCapital
Get started

Precigen PGEN Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
——
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
——
Merck & Co. logo
Merck & Co.MRK
——

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×—

Profitability

See full
Gross margin83.6%—
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, number?
Precigen (PGEN) reported share-based compensation arrangement by share-based payment award, options, outstanding, number of $28.25M in Q1 2026.
How has Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, number changed year-over-year?
Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, number increased by 9.1% year-over-year, from $25.9M to $28.25M.
What is the long-term trend for Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, number?
Over 3 years (2022 to 2025), Precigen's share-based compensation arrangement by share-based payment award, options, outstanding, number has grown at a 22.8% compound annual growth rate (CAGR), from $15.2M to $28.15M.